Oklo stock slides after insider sales disclosures as traders reassess Meta nuclear deal
Oklo shares fell 3.8% to $92.28 Thursday after filings showed CEO Jacob DeWitte and COO Caroline Cochran sold about 45,800 shares each under prearranged Rule 10b5-1 plans. The insider sales followed Oklo’s recent deal with Meta to develop a 1.2-gigawatt nuclear campus in Ohio. Trading volume reached 8.7 million shares. Oklo lagged sector peers as investors watched for updates on licensing and funding.